Showing 3291-3300 of 20413 results for "".
Weekly Check-Up | January 11th 2016
https://reachmd.com/programs/video-library/weekly-check-january-11th-2016/7866/Welcome to the Weekly Check-up on ReachMD for the week of January 11th, 2016. Check out this week's programs: Depression Among Resident Patients An In-Depth Discussion of Multiple Myeloma (CME) The Path to Lung Transplantation: Roles of Extracorporeal Membrane Oxygenation (ECMO) ImplemenUtility of Stereoelectroencephalography in the Treatment of Drug-Resistant Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/utility-of-stereo-electroencephalography-in-the-treatment-of-drug-resistant-epilepsy/48919/Drug-resistant epilepsy, which affects about a third of people with epilepsy, can be effectively treated with epilepsy surgery, leading to seizure freedom in appropriately selected individuals.Genetic Testing in Adults with Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/genetic-testing-in-adults-with-epilepsy/32052/Appropriate treatment of adults with epilepsy requires the practitioner to be familiar with indications for genetic testing, approaches to testing, diagnostic yield, and clinical ramifications of the results.Maui Derm Panel: GLP-1 Agonists Can Help Psoriasis Patients
https://reachmd.com/programs/practical-dermatology/maui-derm-panel-glp-1-agonists-can-help-psoriasis-patients/32917/Only 11% of Maui Derm 2025 audience members polled said they were comfortable prescribing weight-loss drugs, and 49% said they were not at all—but they should be, according to the presenters of “Psoriasis Update 2025” at the conference in Maui, Hawaii.Pharmacology of Emerging Selective Sodium Channel Antagonists for the Treatment of Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/pharmacology-of-emerging-selective-sodium-channel-antagonists-for-the-treatment-of-epilepsy/39904/The development of isoform-selective sodium channel inhibitors that spare GABAergic interneuron function is in its early stages but holds promise as an exciting area of research.6 Emerging Companies Poised to Redefine Medical Aesthetics
https://reachmd.com/topics/energy-based-devices/6-emerging-companies-poised-to-redefine-medical-aesthetics/49011/Neuromodulation Strategies for Lennox-Gastaut Syndrome: A New Frontier
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/neuromodulation-strategies-for-lennox-gastaut-syndrome-a-new-frontier/39964/The evolution of neuromodulation strategies for the management of Lennox- Gastaut syndrome emphasizes the role of targeted thalamic stimulation, the importance of individualized approaches, and the need for further research to optimize treatment efficacy.Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
https://reachmd.com/programs/medical-industry-feature/oral-option-paroxysmal-nocturnal-hemoglobinuria/35649/It wasn’t that long ago that patients diagnosed with paroxysmal nocturnal hemoglobinuria (PNH) had limited treatment options;1 however, even with more options available, hesitancy to start therapy, particularly complement inhibition, still exists for some patients. As a result, knowing how to communExpanding Treatment Options in PNH: Expert Approaches to Personalized Care
https://reachmd.com/programs/medical-industry-feature/pnh-expert-approaches-personalized-care/35651/Managing patients with paroxysmal nocturnal hemoglobinuria (PNH) is never a “one-size-fits-all” approach. With the emergence of a therapy like FABHALTA® (iptacopan), which delivers comprehensive control of intravascular and extravascular hemolysis, we have an option to offer to eligible adult patienCritical Bilateral Carotid Artery Disease Presenting as Hemichorea
https://reachmd.com/programs/practical-neurology/critical-bilateral-carotid-artery-disease-presenting-as-hemichorea/32195/Vascular imaging can be an important test in the diagnostic workup of adult-onset hemichorea, even in the absence of structural brain lesions.